Aquinox Pharmaceuticals Inc. | Mutual Funds
Mutual Funds that own Aquinox Pharmaceuticals Inc.
T Rowe Price Health Sciences Fund
539,731
2.29%
-953,331
0.01%
06/30/2018
Franklin Biotechnology Discovery Fund
469,500
2%
0
0.1%
03/31/2018
T Rowe Price New Horizons Fund
401,502
1.71%
-711,374
0.01%
06/30/2018
Vanguard Extended Market Index Fund
321,821
1.37%
0
0%
07/31/2018
BlackRock Global Funds - World Healthscience Fund
175,183
0.75%
-2,919
0.02%
01/31/2018
Royce Micro Cap Trust
145,397
0.62%
0
0.1%
06/30/2018
T Rowe Price Small Cap Stock Fund
124,105
0.53%
-220,809
0%
06/30/2018
Fidelity Spartan Extended Market Index Fund
103,404
0.44%
0
0%
07/31/2018
VALIC Company I - Health Sciences Fund
93,017
0.4%
0
0.03%
02/28/2018
TD Health Sciences Fund
76,932
0.33%
0
0.03%
12/31/2017
| Address |
887 Great Northern Way
Vancouver British Columbia V5T 4T5
Canada
|
|
Employees
|
- |
| Website |
http://www.aqxpharma.com |
| Updated |
07/08/2019 |
| Aquinox Pharmaceuticals, Inc. operates as a clinical-stage pharmaceutical company. It discovers and develops targeted therapeutics for inflammation and immuno-oncology. It also focuses on anti-inflammatory product candidates targeting SHIP1, which is a key regulator of an important cellular signaling pathway in immune cells, known as the PI3K pathway. |
